News

News

Vaxinano recruits an animal vaccine project leader

Vaxinano recruits an animal vaccine project leader

Wednesday, April 29th 2020

...Read more

Vaxinano, an outsider among the vaccine leaders

Vaxinano, an outsider among the vaccine leaders

27/04/2020

Visit the website Download the article

The Vaxinano's technology, high hope for Covid-19 vaccine

The Vaxinano's technology, high hope for Covid-19 vaccine

Thursday, April 16th 2020

Nasal vaccination with Vaxinano's nanoparticles against flu virus inhibits virus transmission

...Read more

Didier Betbeder, CEO & CSO of Vaxinano, interviewed in Parole d'Experts de La Tribune (french)

Didier Betbeder, CEO & CSO of Vaxinano, interviewed in Parole d'Experts de La Tribune (french)

Wednesday, February 12th 2020

Didier Betbeder, CEO & CSO of Vaxinano, explains how innovative and efficient is its vaccine platform.

...Read more

Vaxinano presents its vaccine platform technology at the french society of immunology

Vaxinano presents its vaccine platform technology at the french society of immunology

Thursday, January 16th 2020

Didier Betbeder, CEO & CSO of Vaxinano, presents the vaccine platform to Vaccinology Club of the French Society for Immunology

...Read more

Vaxinano presents preclinical results of its anti-toxoplasma vaccine

Vaxinano presents preclinical results of its anti-toxoplasma vaccine

Thursday, December 05th 2019

Didier Betbeder, CEO & CSO of Vaxinano, presents for the first time the preclinical results of the anti-toxoplasma vaccine, including non-human primates.

...Read more

New Contract

New Contract

Monday, July 01st 2019

Vaxinano Announces the Signing of a Third Research and Development Program with a Leader in the Vaccine Industry.

...Read more

An <cite>E.coli</cite> vaccine as an alternative to the overuse of antibiotics in poultry

An E.coli vaccine as an alternative to the overuse of antibiotics in poultry

Thursday, June 06th 2019

Faced with the worldwide emergence of antibiotic resistance, Vaxinano obtains funding for research with Immunova Analises Biologicas and Lesaffre International to develop a vaccine against avian colibacillosis.

...Read more

Vaxinano in the selection of the 100 start-ups in which to invest in 2019

Vaxinano in the selection of the 100 start-ups in which to invest in 2019

27/03/2019

Visit the website

New contract

New contract

Wednesday, January 16th 2019

A new pharmaceutical industrial leader trusts Vaxinano for the development of veterinary vaccines.

...Read more

2018 Innovation competition : Vaxinano received by the secretaries of state

2018 Innovation competition : Vaxinano received by the secretaries of state

Tuesday, December 11st 2018

This December 11 was held the award ceremony of the 2018 Innovation competition where Vaxinano was rewarded in the field of Health.

...Read more

Vaxinano presents at the Maison de la Chimie

Vaxinano presents at the Maison de la Chimie

Wednesday, November 07th 2018

...Read more